152 related articles for article (PubMed ID: 12433923)
1. Yersinia effector YopJ inhibits yeast MAPK signaling pathways by an evolutionarily conserved mechanism.
Yoon S; Liu Z; Eyobo Y; Orth K
J Biol Chem; 2003 Jan; 278(4):2131-5. PubMed ID: 12433923
[TBL] [Abstract][Full Text] [Related]
2. Yersinia YopJ acetylates and inhibits kinase activation by blocking phosphorylation.
Mukherjee S; Keitany G; Li Y; Wang Y; Ball HL; Goldsmith EJ; Orth K
Science; 2006 May; 312(5777):1211-4. PubMed ID: 16728640
[TBL] [Abstract][Full Text] [Related]
3. Function of the Yersinia effector YopJ.
Orth K
Curr Opin Microbiol; 2002 Feb; 5(1):38-43. PubMed ID: 11834367
[TBL] [Abstract][Full Text] [Related]
4. Structural requirements for Yersinia YopJ inhibition of MAP kinase pathways.
Hao YH; Wang Y; Burdette D; Mukherjee S; Keitany G; Goldsmith E; Orth K
PLoS One; 2008 Jan; 3(1):e1375. PubMed ID: 18167536
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of MAPK and NF-kappa B pathways is necessary for rapid apoptosis in macrophages infected with Yersinia.
Zhang Y; Ting AT; Marcu KB; Bliska JB
J Immunol; 2005 Jun; 174(12):7939-49. PubMed ID: 15944300
[TBL] [Abstract][Full Text] [Related]
6. Caspase-8 mediates caspase-1 processing and innate immune defense in response to bacterial blockade of NF-κB and MAPK signaling.
Philip NH; Dillon CP; Snyder AG; Fitzgerald P; Wynosky-Dolfi MA; Zwack EE; Hu B; Fitzgerald L; Mauldin EA; Copenhaver AM; Shin S; Wei L; Parker M; Zhang J; Oberst A; Green DR; Brodsky IE
Proc Natl Acad Sci U S A; 2014 May; 111(20):7385-90. PubMed ID: 24799700
[TBL] [Abstract][Full Text] [Related]
7. Serine/threonine acetylation of TGFβ-activated kinase (TAK1) by Yersinia pestis YopJ inhibits innate immune signaling.
Paquette N; Conlon J; Sweet C; Rus F; Wilson L; Pereira A; Rosadini CV; Goutagny N; Weber AN; Lane WS; Shaffer SA; Maniatis S; Fitzgerald KA; Stuart L; Silverman N
Proc Natl Acad Sci U S A; 2012 Jul; 109(31):12710-5. PubMed ID: 22802624
[TBL] [Abstract][Full Text] [Related]
8. Acetylation of MEK2 and I kappa B kinase (IKK) activation loop residues by YopJ inhibits signaling.
Mittal R; Peak-Chew SY; McMahon HT
Proc Natl Acad Sci U S A; 2006 Dec; 103(49):18574-9. PubMed ID: 17116858
[TBL] [Abstract][Full Text] [Related]
9. The Hog1 MAPK prevents cross talk between the HOG and pheromone response MAPK pathways in Saccharomyces cerevisiae.
O'Rourke SM; Herskowitz I
Genes Dev; 1998 Sep; 12(18):2874-86. PubMed ID: 9744864
[TBL] [Abstract][Full Text] [Related]
10. YopJ targets TRAF proteins to inhibit TLR-mediated NF-kappaB, MAPK and IRF3 signal transduction.
Sweet CR; Conlon J; Golenbock DT; Goguen J; Silverman N
Cell Microbiol; 2007 Nov; 9(11):2700-15. PubMed ID: 17608743
[TBL] [Abstract][Full Text] [Related]
11. In vitro signaling by MAPK and NFkappaB pathways inhibited by Yersinia YopJ.
Mukherjee S; Orth K
Methods Enzymol; 2008; 438():343-53. PubMed ID: 18413260
[TBL] [Abstract][Full Text] [Related]
12. The activities of the Yersinia protein kinase A (YpkA) and outer protein J (YopJ) virulence factors converge on an eIF2alpha kinase.
Wiley DJ; Shrestha N; Yang J; Atis N; Dayton K; Schesser K
J Biol Chem; 2009 Sep; 284(37):24744-53. PubMed ID: 19553678
[TBL] [Abstract][Full Text] [Related]
13. Yersinia virulence factor YopJ acts as a deubiquitinase to inhibit NF-kappa B activation.
Zhou H; Monack DM; Kayagaki N; Wertz I; Yin J; Wolf B; Dixit VM
J Exp Med; 2005 Nov; 202(10):1327-32. PubMed ID: 16301742
[TBL] [Abstract][Full Text] [Related]
14. Yersinia YopJ inhibits pro-inflammatory molecule expression in human bronchial epithelial cells.
Zhou L; Tan A; Hershenson MB
Respir Physiol Neurobiol; 2004 Apr; 140(1):89-97. PubMed ID: 15109931
[TBL] [Abstract][Full Text] [Related]
15. Disruption of signaling by Yersinia effector YopJ, a ubiquitin-like protein protease.
Orth K; Xu Z; Mudgett MB; Bao ZQ; Palmer LE; Bliska JB; Mangel WF; Staskawicz B; Dixon JE
Science; 2000 Nov; 290(5496):1594-7. PubMed ID: 11090361
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of MAPK signaling pathways by VopA from Vibrio parahaemolyticus.
Trosky JE; Mukherjee S; Burdette DL; Roberts M; McCarter L; Siegel RM; Orth K
J Biol Chem; 2004 Dec; 279(50):51953-7. PubMed ID: 15459200
[TBL] [Abstract][Full Text] [Related]
17. Disparity between Yersinia pestis and Yersinia enterocolitica O:8 in YopJ/YopP-dependent functions.
Zauberman A; Velan B; Mamroud E; Flashner Y; Shafferman A; Cohen S
Adv Exp Med Biol; 2007; 603():312-20. PubMed ID: 17966427
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of the mitogen-activated protein kinase kinase superfamily by a Yersinia effector.
Orth K; Palmer LE; Bao ZQ; Stewart S; Rudolph AE; Bliska JB; Dixon JE
Science; 1999 Sep; 285(5435):1920-3. PubMed ID: 10489373
[TBL] [Abstract][Full Text] [Related]
19. Yersinia inhibits host signaling by acetylating MAPK kinases.
Bliska JB
ACS Chem Biol; 2006 Jul; 1(6):349-51. PubMed ID: 17163770
[TBL] [Abstract][Full Text] [Related]
20. Yersinia outer protein P suppresses TGF-beta-activated kinase-1 activity to impair innate immune signaling in Yersinia enterocolitica-infected cells.
Haase R; Richter K; Pfaffinger G; Courtois G; Ruckdeschel K
J Immunol; 2005 Dec; 175(12):8209-17. PubMed ID: 16339560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
